SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-266805
Filing Date
2020-10-09
Accepted
2020-10-09 08:31:27
Documents
70
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d271253d10q.htm   iXBRL 10-Q 1306424
2 EX-3.1 d271253dex31.htm EX-3.1 192739
3 EX-31.1 d271253dex311.htm EX-31.1 10835
4 EX-31.2 d271253dex312.htm EX-31.2 10834
5 EX-32.1 d271253dex321.htm EX-32.1 4172
6 EX-32.2 d271253dex322.htm EX-32.2 4157
  Complete submission text file 0001193125-20-266805.txt   7527911

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cydy-20200831.xsd EX-101.SCH 79938
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cydy-20200831_cal.xml EX-101.CAL 37481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cydy-20200831_def.xml EX-101.DEF 507527
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cydy-20200831_lab.xml EX-101.LAB 546357
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cydy-20200831_pre.xml EX-101.PRE 531578
12 EXTRACTED XBRL INSTANCE DOCUMENT d271253d10q_htm.xml XML 927869
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 201232137
SIC: 2834 Pharmaceutical Preparations